摘要
目的:总结、分析宫颈癌诊断中糖类抗原CA125、糖类抗原CA19-9联合检测的应用价值。方法:收治经病理确诊的宫颈癌患者40例作为观察组,同期选择健康体检人员40例作为对照组。测定所有人员血清中的CA125、CA19-9含量水平并进行相关分析。结果:在CA125、CA19-9含量水平方面,观察组高于对照组,差异有统计学意义(P<0.05);在CA125、CA19-9阳性率方面,宫颈鳞癌低于宫颈腺癌,差异有统计学意义(P<0.05);在联合检测的肿瘤标志物阳性率方面,临床Ⅲ/Ⅳ期高于临床Ⅰ/Ⅱ期,差异有统计学意义(P<0.05)。结论:CA125、CA19-9联合检测在宫颈癌患者鉴别诊断以及分期的确定中均发挥着重要作用。
Objective:To summarize and analyze the value of combined detection of carbohydrate antigen CA125 and carbohydrate antigen CA19 in the diagnosis of cervical cancer.Methods:40 cases of cervical cancer diagnosed by pathology were selected as the observation group.At the same time,40 health workers were selected as control group.The serum levels of CA125 and CA19-9 in all personnel were measured and analyzed.Results:In the content of CA125 and CA19-9,the observation group was higher than that of the control group,and the difference was statistically significant(P<0.05).In the positive rate of CA125 and CA19-9,cervical squamous cell carcinoma is lower than adenocarcinoma of the cervix,and the difference was statistically significant(P<0.05).In the combined detection of tumor markers positive rate,the clinical stage Ⅲ/Ⅳ was higher than the clinical stage Ⅰ/Ⅱ,and the difference was statistically significant(P<0.05).Conclusion:The combined detection of CA125 and CA19-9 plays an important role in differential diagnosis and staging of cervical cancer.
出处
《中国社区医师》
2017年第31期89-90,共2页
Chinese Community Doctors
